Marc R. Radke - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Marc R. Radke's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today

Marc R. Radke

Verified

Editor-in- Chief, DAS INVESTMENT

Beats

Primary beats

u.s. regional crime and justice

Secondary beats

Legal coverage Sports Mundo Geek Corruption Reproductive Justice Law Firm Crime and corruption Cannabis Justice Law Law Firms Environment Art International Affairs Capitol Hill Inequality City Government

Final Covers

Motherhood , Culture, Feminism , Health, Tech, Opinion

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 1

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984 | Journal of Clinical Oncology
By Joseph Kim, Rana R. McKay, Shilin Zhao, Marc R. Radke · ascopubs.org
Oct. 18, 2022

As seen in

Das Investment

Company Info

DAS INVESTMENT

Hamburg, Hamburg, Germany

'+49 40 40199950

Founded: 1999